Vaccines have been used for years to prevent infectious illnesses such as tuberculosis (TB) and measles. They work by helping the immune system recognise abnormal cells in the body and attack them. Cancer vaccines are now being developed as a new type of cancer treatment but are still in the early stages of development. They aim to help the immune system recognise cancer cells.

Cancer vaccines are made from a person’s own cancer cells, someone else’s cancer cells or cells grown in a laboratory. As the vaccine is similar to the cancer cells, it's hoped that the immune system will be stimulated to attack and destroy them.

There are also vaccines to prevent a virus called the human papilloma virus (HPV), which can cause cervical cancer.

Cancer vaccines are usually given by injection and possible side effects include a skin reaction and flu-like symptoms.

When a new treatment is being developed, it goes through various stages of research called clinical trials. Some vaccines for certain cancers are being tested to see if they can treat cancer or stop it returning. Ask your doctor or nurse for more information about current research trials for cancer vaccines.


Cancer vaccines are a new type of cancer treatment and are still in the early stages of development. This information is about how vaccines can be used to treat cancer.

Vaccines have been used for many years as a way of preventing infectious illnesses such as flu, tuberculosis (TB), measles, mumps, typhoid and German measles. Vaccines stimulate the body’s immune system to recognise and fight abnormal ‘foreign’ cells in the body, such as viruses and bacteria.

Scientists and doctors are now trying to develop vaccines that can stimulate the immune system to recognise and destroy cancer cells.

Some vaccines for particular cancers have been developed. These are being tested to see whether they can treat the cancer or help stop it coming back after treatment. You may be asked to take part in a research trial that includes a new vaccine.

Vaccines are also used to prevent viruses that can cause cancer. In the UK, all 12–13-year-old girls are routinely offered the HPV vaccine, which helps prevent the human papilloma virus (HPV). HPV can cause cervical cancer. Another vaccine, called the HBV vaccine, is used to prevent hepatitis B, which can cause a type of liver cancer. In the UK, the HBV vaccine is usually only given to people at high risk of developing hepatitis B. It’s only routinely offered in some Asian countries, where hepatitis is far more common.

This information is about vaccines to treat cancer. We have separate information about the HPV vaccine to prevent cancer.

Some people with early bladder cancer are treated using the BCG vaccine that is used to prevent tuberculosis. The vaccine is put into the bladder and helps stop early bladder cancers from coming back (recurring). Although BCG is a vaccine, it is not a cancer vaccine.

We have more information about the use of BCG in bladder cancer.

The immune system

Our immune system protects us from infection and disease. It is a complex system made up of the bone marrow, the thymus gland (which lies behind the breast bone), the spleen and the lymph nodes (or lymph glands).

Lymphocytes are a type of white blood cell and one of the most important parts of our immune system. These are made in the bone marrow and circulate around the body in the blood and lymph vessels. They recognise unwanted or abnormal cells and act quickly to destroy them.

There are two types of lymphocytes: B-cells and T-cells. B-cells develop into plasma cells that make specialised proteins called antibodies. Antibodies circulate in the blood and react with toxins, bacteria and some cancer cells. The body can then identify and remove these unwanted cells.

However, some foreign substances in the body can hide from the B-cells by growing within the body’s own cells. T-cells can sense when the body’s own cells have become abnormal and can destroy them. The whole process is known as an immune response.

After the abnormal cells or bacteria have been destroyed, the surviving B-cells and T-cells develop into specialised memory cells. They remain on watch in the lymph nodes and are reactivated if that particular abnormal cell or substance appears in the body again.

The immune response

Abnormal cells usually have proteins (antigens) on their surface. The T-cells and B-cells recognise these proteins as foreign or abnormal.

The B-cells produce antibodies that attach to the antigens and attract the T-cells. Together they destroy the abnormal cells.

Cancer and the immune system

The human body is made up of tiny building blocks called cells. Cells look and function differently throughout the body, but reproduce and repair themselves in the same way. This process normally happens in an organised and controlled manner. If cells become cancerous they start to divide in an uncontrolled way and don't die when they should.

The immune system sometimes has difficulty recognising cancer cells and doesn't destroy them. The cancer cells then continue to grow.

Research has also shown that many cancers actually suppress the immune system, making it less effective overall.

The aim of cancer vaccines

The aim of cancer vaccines is to stimulate the immune system to be able to recognise cancer cells as abnormal and destroy them.

Other cancer vaccines, known as immune restorers or immune modulators, aim to boost the immune system to work more effectively.

How cancer vaccines are made

Cancer vaccines are made from:

  • the person’s own cancer cells
  • someone else’s cancer cells
  • cells that are grown in a laboratory.

The cancer cells are treated with heat or radiation. This is so that they cannot multiply and grow and to make sure that they cannot cause harm.

Certain proteins may then be taken from the cancer cells and used to make a cancer vaccine. These include:

  • antigens, which are the proteins on the cell surface that can stimulate an immune response.
  • endritic cells, which help the immune system recognise and attack abnormal cells.

Sometimes whole cells may be used to make the vaccine, or sometimes just bits of the cancer cell’s DNA will be used.

As the cancer vaccine contains similar proteins to the cancer cells, it's hoped that the immune system will be stimulated to attack and destroy them.

How cancer vaccines are given

Cancer vaccines are usually a liquid that's given by an injection under the skin (subcutaneously). How often they are given will depend on the type of cancer being treated and the type of vaccine being used.

Vaccines are often given in combination with other cancer treatment, such as chemotherapy.

Possible side effects

The possible side effects of cancer vaccines include a skin reaction at the injection site, a skin rash or mild flu-like symptoms. Certain cancer vaccines may cause more specific symptoms and you should be told about these by your nurse or doctor before starting treatment.

Research trials

Vaccines are being used in research trials. When a new treatment is being developed it needs to go through various stages of research called clinical trials.

Most trials with cancer vaccines are treating people with advanced cancers that can't be cured. However, some research is looking at treating cancers at an earlier stage. It's possible that vaccines may be used to try to prevent different types of cancer at some time in the future.

Currently most of the research into vaccines has looked at cancer of the prostate gland, breast, pancreas, colon and rectum, lung, skin (mainly malignant melanoma), kidney, ovary, bladder and cervix. Vaccines have also been used to treat lymphoma and leukaemia.

The results so far

Cancer vaccines have been researched for many years. Some studies on laboratory animals, such as mice, have shown promising results in which vaccines have successfully stimulated the immune system. Research has not always been so successful in humans. However, recent studies have shown more encouraging results.

The reasons why previous studies have been unsuccessful are not fully understood. A number of theories have been suggested which include:

  • many people with cancer have reduced immunity and so their immune systems are not able to react to the vaccines
  • some tumours produce proteins and chemicals that prevent the immune system from attacking them effectively, even when the immune system has been stimulated by the vaccine
  • not all tumour cells are the same, and some cells may be different from those in the vaccine - those different cells will be resistant to, and unaffected by, the vaccine
  • some cancer vaccines may not have been given in large enough doses.

If you have any questions about cancer vaccines, talk to your doctor or nurse. It is also important to tell them if you have any symptoms or side effects that may be related to your treatment.

Back to Targeted therapy explained

Angiogenesis inhibitors

Angiogenesis inhibitors are drugs that make it difficult for a tumour to develop a blood supply.

Cancer growth inhibitors

Cancer growth inhibitors are drugs that block signals that tell cancer cells to develop or divide.

Monoclonal antibodies

Monoclonal antibodies attach to receptors on the surface of cancer cells or other cells in the body.